Comparison of contemporary devices used for transcatheter patent foramen ovale closure

Journal of Invasive Cardiology

Volumn 20, Issue 9, 2008, Pages 442-447

  Spies, Christian ^b   Reissmann, Ulrich ^c   Timmermanns, Ines ^d   Schräder, Rainer ^a,c,d  

^a AGAPLESION MARKUS KRANKENHAUS   (Germany)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c Medizinische Klinik III   (Germany)

^d CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEATH; DEVICE; EQUIPMENT DESIGN; EXPLANT; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART CATHETER; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; PERICARDIAL EFFUSION; PREDICTOR VARIABLE; RECURRENT DISEASE; SHUNTING; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; CARDIOVASCULAR SURGICAL PROCEDURES; EQUIPMENT AND SUPPLIES; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; THROMBOSIS; TREATMENT OUTCOME;

EID: 50849140153     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bridges ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902-1908.
2. Sievert H, Babic UU, Hausdorf G, et al. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol 1998;82:1405-1413.
3. Du ZD, Cao QL, Joseph A, et al. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: Intermediate-term risk of recurrent neurological events. Catheter Cardiovasc Interv 2002;55:189-194.
4. Hung J, Landzberg MJ, Jenkins KJ, et al. Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement . J Am Coll Cardiol 2000;35:1311-1316.
5. Rickers C, Hamm C, Stern H, et al. Percutaneous closure of secundum atrial septal defect with a new self centering device ("angel wings"). Heart 1998;80:517-521.
6. Hellmuller B, Kaufmann U, Aeschbacher B, et al. [Catheter closure in atrial septal defects and open foramen ovale using the Sideris buttoned device]. Schweiz Med Wochenschr 1996;126:1143-1150.
7. Hong TE, Thaler D, Brorson J, et al. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: Initial and intermediate-term results of the U.S. multicenter clinical trial. Catheter Cardiovasc Interv 2003;60:524-528.
8. Chatterjee T, Petzsch M, Ince H, et al. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism. J Interv Cardiol 2005;18:173-179.
9. Spies C, Strasheim R, Timmermanns I, Schraeder R. Patent foramen ovale closure in patients with cryptogenic thrombo-embolic events using the Cardia PFO occluder. Eur Heart J 2006;27:365-371.
10. Spies C, Timmermanns I, Reissmann U, et al. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism. Catheter Cardiovasc Interv 2008;71:390-395.
11. Schwerzmann M, Windecker S, Wahl A, et al. Percutaneous closure of patent foramen ovale: Impact of device design on safety and efficacy. Heart 2004;90:186-190.
12. Braun M, Gliech V, Boscheri A, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004;25:424-430.
13. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-898.
14. Carminati M, Chessa M, Butera G, et al. Transcatheter closure of atrial septal defects with the STARFlex device: Early results and follow-up. J Interv Cardiol 2001;14:319-324.
15. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: A systematic review. Ann Intern Med 2003;139:753-760.
16. Wahl A, Kunz M, Moschovitis A, et al. Long-term results after fluoroscopy guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart 2008;94:336-341.
17. Alaeddini J, Feghali G, Jenkins S, et al. Frequency of atrial tachyarrhythmias following transcatheter closure of patent foramen ovale. J Invasive Cardiol 2006;18:365-368.
18. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies. Neurology 2000;55:1172-1179.
19. Handke M, Harloff A, Olschewski M, et al. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007;357:2262-2268.
20. Majunke N, Sievert H. ASD/PFO devices: What is in the pipeline? J Interv Cardiol 2007;20:517-523.